301 related articles for article (PubMed ID: 8828478)
1. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos.
Roberts VJ; Bentley CA; Guo Q; Matzuk MM; Woodruff TK
Endocrinology; 1996 Oct; 137(10):4201-9. PubMed ID: 8828478
[TBL] [Abstract][Full Text] [Related]
2. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis.
Roberts VJ; Barth SL
Endocrinology; 1994 Feb; 134(2):914-23. PubMed ID: 8299586
[TBL] [Abstract][Full Text] [Related]
3. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
4. Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins.
Feijen A; Goumans MJ; van den Eijnden-van Raaij AJ
Development; 1994 Dec; 120(12):3621-37. PubMed ID: 7821227
[TBL] [Abstract][Full Text] [Related]
5. Uterine-embryonic interaction in pig: activin, follistatin, and activin receptor II in uterus and embryo during early gestation.
van de Pavert SA; Boerjan ML; Stroband HW; Taverne MA; van den Hurk R
Mol Reprod Dev; 2001 Aug; 59(4):390-9. PubMed ID: 11468775
[TBL] [Abstract][Full Text] [Related]
6. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
Kaipia A; Toppari J; Huhtaniemi I; Paranko J
Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
9. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
10. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
[TBL] [Abstract][Full Text] [Related]
11. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo.
Leal AM; Takabe K; Wang L; Donaldson CJ; MacConell LA; Bilezikjian LM; Verma IM; Vale W
Endocrinology; 2002 Mar; 143(3):964-9. PubMed ID: 11861519
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mouse follistatin causes reproductive defects in transgenic mice.
Guo Q; Kumar TR; Woodruff T; Hadsell LA; DeMayo FJ; Matzuk MM
Mol Endocrinol; 1998 Jan; 12(1):96-106. PubMed ID: 9440814
[TBL] [Abstract][Full Text] [Related]
13. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
[TBL] [Abstract][Full Text] [Related]
14. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development.
Tuuri T; Erämaa M; Hildén K; Ritvos O
J Clin Endocrinol Metab; 1994 Jun; 78(6):1521-4. PubMed ID: 8200957
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
[TBL] [Abstract][Full Text] [Related]
16. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
[TBL] [Abstract][Full Text] [Related]
17. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
18. In situ ligand binding of recombinant human [125I] activin-A and recombinant human [125I]inhibin-A to the adult rat ovary.
Woodruff TK; Krummen L; McCray G; Mather JP
Endocrinology; 1993 Dec; 133(6):2998-3006. PubMed ID: 8243328
[TBL] [Abstract][Full Text] [Related]
19. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle.
Halvorson LM; Weiss J; Bauer-Dantoin AC; Jameson JL
Endocrinology; 1994 Mar; 134(3):1247-53. PubMed ID: 8119165
[TBL] [Abstract][Full Text] [Related]
20. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
